Has Nancy Goudas received payments from drug or device companies?

Yes. Drug and device makers reported $9,233 in general payments to Nancy Goudas across 429 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nancy Goudas did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nancy Goudas come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nancy Goudas

Nurse Practitioner · Hickory, NCNPI 1396292017

Payments from drug & device makers

$9,233in general payments, 2019–2025

Across 429 payments — averaging $21.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$741
AstraZeneca$643
Merck$574
Incyte Corporation$570
Johnson & Johnson$471
AbbVie$357
plus $6K from 54 others

What the payments were for

Food & beverage$8,44491%
Education$7899%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	40	$741
AstraZeneca(2 entities)	34	$643
Merck	29	$574
Incyte Corporation	21	$570
Johnson & Johnson	24	$471
AbbVie	12	$357
Astellas Pharma US Inc	11	$350
Takeda Pharmaceuticals U.S.A., Inc.	12	$332
Eisai Inc.	12	$256
Seagen Inc.	9	$251
Exelixis Inc.	11	$225
Lilly USA, LLC	12	$219
Bayer	9	$204
AVEO Pharmaceuticals, Inc.	8	$200
E.r. Squibb & Sons, L.L.C.	10	$200
Pfizer	12	$199
Pharmacyclics LLC, An Abbvie Company	4	$189
Ipsen Biopharmaceuticals, Inc	8	$161
Regeneron Healthcare Solutions, Inc.	8	$155
Karyopharm Therapeutics Inc.	6	$151
Daiichi Sankyo Inc.	7	$151
Servier Pharmaceuticals LLC	8	$146
Beigene USA, Inc.	8	$141
GSK	7	$138
Pharmaessentia USA Corporation	6	$131
Sanofi	5	$131
Genentech USA, Inc.	5	$121
Deciphera Pharmaceuticals Inc.	5	$114
Sobi, Inc	6	$111
Array Biopharma Inc	6	$106
Myriad Genetic Laboratories, Inc.	3	$106
Bristol Myers Squibb	5	$93
Novocure Inc.	4	$89
Jazz Pharmaceuticals Inc.	4	$80
Beone Medicines USA, Inc.	3	$76
Acrotech Biopharma Inc.	3	$64
Epizyme, Inc.	4	$58
Genmab U.S., Inc.	2	$57
Taiho Oncology, Inc.	3	$56
Mirati Therapeutics, Inc.	3	$55
Boehringer Ingelheim	2	$50
Caris MPI, Inc.	2	$49
Sun Pharmaceutical Industries Inc.	2	$46
ADC Therapeutics America, Inc.	3	$45
Springworks Therapeutics, Inc.	2	$40
Gilead	2	$39
Azurity Pharmaceuticals, Inc.	2	$39
Morphosys, US Inc.	2	$39
Stemline Therapeutics Inc.	2	$39
Coherus Oncology, Inc.	2	$39
Celltrion USA Inc.	2	$34
Geron Corporation	1	$22
Menarini Silicon Biosystems, Inc.	1	$22
Puma Biotechnology, Inc.	1	$21
Kyowa Kirin, Inc.	1	$20
TG Therapeutics, Inc.	1	$19
GE HealthCare	1	$18
Pharmacosmos Therapeutics Inc.	1	$17
Cumberland Pharmaceuticals, Inc.	1	$17
Apellis Pharmaceuticals, Inc.	1	$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ICLUSIG$125

How this compares

$9,233 in reported general payments places this provider in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.

See all nurse practitioner providers in North Carolina →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
NubeqaDarolutamide	11	$140,359
EliquisApixaban	67	$54,228
Anastrozole	88	$1,618
Tamoxifen Citrate	65	$1,618
ValacyclovirValacyclovir Hcl	14	$697
Hydroxyurea	33	$678
Ondansetron Hcl	35	$370
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	12	$265
Acyclovir	25	$149
Prednisone	33	$126
Promethazine Hcl	13	$85
Zolpidem Tartrate	11	$81
Levofloxacin	11	$67
Potassium Chloride	11	$39

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
BayerNubeqa	$204	$140,35911 claims
PfizerEliquis	$199	$54,22867 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,393 nurse practitioner providers in North Carolina.

Other nurse practitioner in Hickory

Sandrivette JohnsonRaleigh$573K
Skyler RogersPinehurst$174K
Jamie DinerDurham$170K
Ayeshia WrightMocksville$145K
Deborah AllenDurham$112K
Jeanann VawterGastonia$97K
Terra KampJacksonville$72K
Mary DilorenzoCharlotte$71K
Olivia OgburnWinston Salem$70K
Bridget ArchambaultDurham$57K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →